CClinicalTrials.gg
CompletedNCT01692509Updated Jun 9, 2015

Non Invasive Ventilation (NIV) Related Practices, Monitoring of the NIV Treatment Effect and of the Patient's Comfort

An observational study in Respiratory Failure Requiring Non Invasive Ventilation, sponsored by University of Lausanne Hospitals. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-06-09.

Sponsored by University of Lausanne Hospitals · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

The practices and processes related to the administration of noninvasive ventilation (NIV) in the adult intensive care unit (ICU) of the University hospital of Lausanne will be recorded by an investigator at the bedside. The effect of the NIV treatment on various respiratory parameters ( respiratory rate, expired tidal volume, minute ventilation) will also be recorded using a pneumotachograph. Finally patient's comfort during NIV treatment will be evaluated.

02

Conditions studied

  • Respiratory Failure Requiring Non Invasive Ventilation

Keywords

  • Non invasive ventilation
  • Respiratory failure
  • Respiratory comfort
03

In context

Respiratory Insufficiency

1,650 studies on the registry are indexed under Respiratory Insufficiency; 296 are open to participants now.

This study's enrollment of 30 is below the median of 100 across 545 observational studies indexed under Respiratory Insufficiency.

Browse Respiratory Insufficiency studies →

Lead sponsor

University of Lausanne Hospitals is the lead sponsor of 118 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients hospitalized in the CHUV intensive care unit who require non invasive ventilation because of respiratory failure.

Inclusion criteria

  • Respiratory failure
  • Therapeutic treatment by NIV required

Exclusion criteria

Exclusion Criteria:

  • Age \< 18 years old
  • Prophylactic NIV treatment
  • Continuous Positive Airway Pressure (CPAP)treatment
  • Denied consent
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (actual)

Groups and cohorts

  • Patients requiring NIV

    Patients requiring NIV because of acute respiratory failure

06

What researchers measure

Primary outcomes

  1. Documentation of practices and processes related to NIV treatment

    Documentation of practices and processes related to NIV administration in the adult intensive care unit(type of ventilator used, type of interface chosen, initial settings, organization of the care team and interactions between caregivers).

Secondary outcomes

  1. Patient's Respiratory comfort

    Patient's respiratory comfort during NIV will be assessed both by the patients themselves with a visual analogic scale and by the investigator.

  2. Ventilatory parameters

    Tidal volume, respiratory rate, inspiratory time, expiratory time and maximal and mean airway pressure will be measured from the continuous recording of airway pressure and flow obtained with a pneumotachograph.

07

Study locations

1 site
  • Intensive care and burn unit, University Hospital of Lausanne
    Lausanne, Switzerland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 9, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01692509
Lead sponsor
University of Lausanne Hospitals
Responsible party
Prof. Philippe Jolliet (Main investigator, University of Lausanne Hospitals) — Principal investigator
First posted
Sep 25, 2012
Start date
Apr 2012
Primary completion
Jun 2013
Completion
Jun 2013
Last update
Jun 9, 2015

Study contacts

Philippe Jolliet, Professor
principal investigator · University of Lausanne Hospitals

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion